These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17977261)
1. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261 [TBL] [Abstract][Full Text] [Related]
7. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome. Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012 [TBL] [Abstract][Full Text] [Related]
8. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646 [TBL] [Abstract][Full Text] [Related]
9. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836 [TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiation therapy for vestibular schwannomas: Dosimetric factors predictive of hearing outcomes. Bennion NR; Nowak RK; Lyden ER; Thompson RB; Li S; Lin C Pract Radiat Oncol; 2016; 6(5):e155-e162. PubMed ID: 26961715 [TBL] [Abstract][Full Text] [Related]
11. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739 [TBL] [Abstract][Full Text] [Related]
12. Hearing outcomes after stereotactic radiosurgery for unilateral intracanalicular vestibular schwannomas: implication of transient volume expansion. Kim YH; Kim DG; Han JH; Chung HT; Kim IK; Song SW; Park JH; Kim JW; Kim YH; Park CK; Kim CY; Paek SH; Jung HW Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):61-7. PubMed ID: 22580122 [TBL] [Abstract][Full Text] [Related]
13. Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Paek SH; Chung HT; Jeong SS; Park CK; Kim CY; Kim JE; Kim DG; Jung HW Cancer; 2005 Aug; 104(3):580-90. PubMed ID: 15952200 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. Hasegawa T; Kida Y; Kato T; Iizuka H; Yamamoto T J Neurosurg; 2011 Dec; 115(6):1078-86. PubMed ID: 21961962 [TBL] [Abstract][Full Text] [Related]
15. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing. Han JH; Kim DG; Chung HT; Paek SH; Jung HW Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404 [TBL] [Abstract][Full Text] [Related]
16. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832 [TBL] [Abstract][Full Text] [Related]
17. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers. Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864 [TBL] [Abstract][Full Text] [Related]
19. Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. Carlson ML; Jacob JT; Pollock BE; Neff BA; Tombers NM; Driscoll CL; Link MJ J Neurosurg; 2013 Mar; 118(3):579-87. PubMed ID: 23101446 [TBL] [Abstract][Full Text] [Related]
20. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]